SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-21-000032
Filing Date
2021-10-29
Accepted
2021-10-29 13:55:44
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20210930.htm   iXBRL 10-Q 2255635
2 EX-31.1 exhibit311-30sep21x10q.htm EX-31.1 8896
3 EX-31.2 exhibit312-30sep21x10q.htm EX-31.2 9139
4 EX-32.1 exhibit321-30sep21x10q.htm EX-32.1 5249
  Complete submission text file 0001048477-21-000032.txt   8930231

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20210930.xsd EX-101.SCH 48243
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20210930_cal.xml EX-101.CAL 76071
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20210930_def.xml EX-101.DEF 249604
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20210930_lab.xml EX-101.LAB 554000
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20210930_pre.xml EX-101.PRE 380496
10 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20210930_htm.xml XML 1944150
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 211362295
SIC: 2834 Pharmaceutical Preparations